Finch Therapeutics Group Inc

NAS:FNCH (USA)  
$ 4.19 +0.35 (+9.11%) 10:08 PM EST
At Loss
P/B:
0.24
Volume:
60.04K
Avg Vol (2M):
6.49K
Volume:
60.04K
At Loss
Avg Vol (2M):
6.49K

Business Description

Description
Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs. It is developing novel therapeutics to deliver missing microbes and their clinically relevant biochemical functions to correct dysbiosis and the diseases that emerge from it. The lead product candidate is CP101 which delivers a complete microbiome and is being developed initially for the treatment of patients with recurrent Clostridioides difficile infection.
Name Current Vs Industry Vs History
Cash-To-Debt 0.94
Equity-to-Asset 0.43
Debt-to-Equity 1.19
Debt-to-EBITDA -0.55
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -13.31
Distress
Grey
Safe
Beneish M-Score -7.16
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 79.34
9-Day RSI 65.16
14-Day RSI 55.82
6-1 Month Momentum % -53.81
12-1 Month Momentum % -86.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.13
Quick Ratio 6.13
Cash Ratio 5.9
Days Sales Outstanding 449.64

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.5
Shareholder Yield % -93.05

Financials (Next Earnings Date:2024-03-22 Est.)

FNCH's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FNCH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Finch Therapeutics Group Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.115
EPS (TTM) ($) -62.54
Beta 0
Volatility % 59.38
14-Day RSI 55.82
14-Day ATR ($) 0.380959
20-Day SMA ($) 3.83241
12-1 Month Momentum % -86.8
52-Week Range ($) 3.35 - 30.6
Shares Outstanding (Mil) 1.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Finch Therapeutics Group Inc Filings

Filing Date Document Date Form
No Filing Data

Finch Therapeutics Group Inc Stock Events

Event Date Price($)
No Event Data

Finch Therapeutics Group Inc Frequently Asked Questions

What is Finch Therapeutics Group Inc(FNCH)'s stock price today?
The current price of FNCH is $4.19. The 52 week high of FNCH is $30.60 and 52 week low is $3.35.
When is next earnings date of Finch Therapeutics Group Inc(FNCH)?
The next earnings date of Finch Therapeutics Group Inc(FNCH) is 2024-03-22 Est..
Does Finch Therapeutics Group Inc(FNCH) pay dividends? If so, how much?
Finch Therapeutics Group Inc(FNCH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1